FIELD: medicine.
SUBSTANCE: invention relates to chemical and pharmaceutical industry and represents implanted medical device, which contains: intra-lumen implanted construction; first coating, containing combination of rapamycin and probucol in therapeutic doses, enclosed in first polymer material, first coating being connected to the surface of intra-lumen implanted construction; and second coating, containing second polymer coating, containing second polymer material, connected to first coating, for regulation of rate of rapamycin and probucol eluting, second polymer material containing fluoropolymer.
EFFECT: invention provides treatment and prevention of disease and minimisation of organism response to introduction of medical device, stimulates healing and endoepithelisation, as well as provides control over rates of drug eluting from implanted medical devices and prevents restenosis.
49 cl, 7 ex, 97 dwg
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
BARE METAL STENT WITH MEDICATION-RELEASING RESERVOIRS | 2011 |
|
RU2573107C2 |
LOCAL DELIVERY OF COMBINATION OF ADENOSINE A2A RECEPTOR AGONISTS/PHOSPHODIESTERASE INHIBITOR IN VESSELS TO RELIEVE MYOCARDIAL INVOLVEMENT SEVERITY | 2011 |
|
RU2565403C2 |
ELUTING STENT WITH CONTAINERS | 2010 |
|
RU2541753C2 |
COATING FOR MEDICAL DEVICE CONTAINING ANTITHROMBOTIC CONJUGATE | 2008 |
|
RU2472529C2 |
ENDOLUMINAL PROSTHESIS CONTAINING MEDICAL AGENT | 2004 |
|
RU2360646C2 |
Authors
Dates
2013-05-10—Published
2008-03-27—Filed